An observational study in Patients Implanted With a Pacemaker, sponsored by LivaNova. Completed at 129 sites in 11 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-14.
Sponsored by LivaNova · Observational
Observational study to assess AV block incidence and their evolution according to paroxysmal atrial arrhythmia.
34 studies on the registry are indexed under Cardiac Conduction System Disease; 9 are open to participants now.
This study's enrollment of 1,440 is above the median of 705 across 18 observational studies indexed under Cardiac Conduction System Disease.
Browse Cardiac Conduction System Disease studies →LivaNova is the lead sponsor of 39 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patient primo-implanted with a pacemaker (Symphony ™ DR2550, Symphony ™ D 2450, Reply DR, Reply D or any similar or higher range) device less than three months ago, programmed in SafeR mode.
Exclusion Criteria:
High degree AV blocks
Time frame: 2 years
Showing the first 100 of 129 sites across 11 countries.
This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cardiac Conduction System Disease→
LivaNova